Not Yet Recruiting 2-HOBA Supplementation in People With Elevated Lipoprotein(a) NCT07198009 Conditions Dyslipidemias, Elevated Lp(a), Hyperlipidemia, +4 more Locations Lipid Clinic at Brown University Health — Providence, Rhode Island, United States View Trial Details
Completed Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a) NCT04606602 Conditions Dyslipidemias, Elevated Lp(a), Hyperlipidemias, +4 more Locations Jacksonville Center for Clinical Research Ltd. — Jacksonville, Florida, United States Progressive Medical Research — Port Orange, Florida, United States Metabolic and Atherosclerosis Research Center — Cincinnati, Ohio, United States Cleveland Clinic — Cleveland, Ohio, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed A Study on the Effects of TA-8995 on Lp(a) in Subjects With Elevated Lp(a) NCT02241772 Conditions Elevated Lp(a) Locations Herlev Hospital — Herlev, Denmark View Trial Details
Active, Not Recruiting A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) NCT06292013 Conditions Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +4 more Locations Birmingham Clinical Research — Birmingham, Alabama, United States Alliance for Multispecialty Research, LLC — Daphne, Alabama, United States SEC Clinical Research — Dothan, Alabama, United States Alliance for Multispecialty Research, LLC — Mobile, Alabama, United States View all 931 locations View more locations Show fewer locations Loading locations... View Trial Details
